Parechovirus Infection in Early Childhood and Association With Subsequent Celiac Disease

German Tapia1, Kateřina Chudá, Christian R Kahrs

  • 11Department of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway; 2Department of Paediatric, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic; 3Department of Pediatrics, Østfold Hospital Trust, Grålum, Norway; 4Department of Pediatrics, Institute of Clinical Sciences, The Sahlgrenska Academy at University of Gothenburg and Queen Silvia Children's Hospital, Gothenburg, Sweden; 5Division of Institute Resources, Department of IT and e-health, Norwegian Institute of Public Health, Oslo, Norway; 6Department of Pediatric Research, Oslo University Hospital, Oslo, Norway.

Insights

Early-life parechovirus infections were linked to a higher risk of developing celiac disease (CD) in children genetically predisposed to the condition. This study highlights parechovirus as a potential factor in celiac disease development.

Area of Science:

  • Virology
  • Gastroenterology
  • Immunology

Background:

  • Celiac disease (CD) is an autoimmune disorder triggered by gluten ingestion in genetically susceptible individuals.
  • Enteric viruses are common in early childhood, and their role in immune-mediated diseases is under investigation.
  • Previous research suggests a potential link between viral infections and the development of autoimmune conditions.

Purpose of the Study:

  • To investigate the association between parechovirus and anellovirus infections and the subsequent development of celiac disease (CD).
  • To determine if increased frequency of parechovirus infections precedes the development of transglutaminase 2 (TG2) antibodies in children who later develop CD.
  • To explore anellovirus as a potential marker of immune status in relation to CD development.

Main Methods:

  • A matched case-control study nested within a longitudinal birth cohort (MIDIA study) of genetically at-risk children.
  • Retrospective analysis of blood samples for TG2 antibody development and monthly stool samples for viral quantification using real-time PCR.
  • Matching of 25 CD cases with 50 control children based on follow-up time, birthdate, and county of residence.

Main Results:

  • Parechovirus was detected more frequently in stool samples from children who later developed CD, particularly before TG2 antibody development (adjusted odds ratio 1.67, P = 0.01).
  • The association was stronger when samples were positive for both parechovirus and enterovirus (adjusted odds ratio 4.73, P = 0.02).
  • Anellovirus was detected frequently but showed no significant difference between CD cases and controls.

Conclusions:

  • Early-life parechovirus infections are associated with an increased risk of developing celiac disease in genetically predisposed children.
  • Parechovirus may play a role in the pathogenesis of celiac disease.
  • Anellovirus does not appear to be a significant factor or marker in the development of CD in this cohort.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
511
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
554
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.7K